(SUPN) Supernus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Supernus Pharmaceuticals | (SUPN) share price targets
Complete technical analysis of Supernus Pharmaceuticals (SUPN) by charts plus indicators, forecast predictions and share price targets for Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-06 View latest technical analysis
10 day averaged volume of Supernus Pharmaceuticals is 822391
| Date | Daily Closing Price | Open | High | Low | Volume |
| 06 Thu Mar 2025 | 31.82 | 31.67 | 32.20 | 31.28 | 0.608 times |
| 05 Wed Mar 2025 | 31.99 | 31.55 | 32.03 | 31.30 | 1.026 times |
| 04 Tue Mar 2025 | 31.65 | 31.43 | 31.98 | 31.28 | 1.029 times |
| 03 Mon Mar 2025 | 31.74 | 32.01 | 32.21 | 31.37 | 0.93 times |
| 28 Fri Feb 2025 | 32.06 | 31.65 | 32.08 | 31.13 | 0.822 times |
| 27 Thu Feb 2025 | 31.76 | 31.91 | 32.74 | 31.44 | 0.858 times |
| 26 Wed Feb 2025 | 31.91 | 33.59 | 34.10 | 30.37 | 1.766 times |
| 25 Tue Feb 2025 | 32.81 | 32.84 | 33.50 | 31.61 | 1.169 times |
| 24 Mon Feb 2025 | 32.68 | 33.36 | 34.05 | 32.44 | 0.886 times |
| 21 Fri Feb 2025 | 33.05 | 34.74 | 34.87 | 32.98 | 0.922 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 31.8 as stoploss in an intra day buy trade for a target of 35.04. However, stock will show a bearish move below 31.8.
Share price targets for Supernus Pharmaceuticals (SUPN)
| Target Type | Value |
| Downside Target | 30.37 |
| Downside Target | 31.28 |
| Upside Target | 32.21 |
| Upside Target | 33.43 |
| Upside Target | 34.10 |
| Upside Target | 36.10 |
| Upside Target | 37.43 |
| Upside Target | 39.37 |
| Upside Target | 39.59 |
| Upside Target | 39.88 |
| Upside Target | 39.99 |
| Upside Target | 40.28 |
Intraday share price targets for Supernus Pharmaceuticals (SUPN)
| Target Type | Value |
| Downside Intraday Target | 31.33 |
| Downside Intraday Target | 30.84 |
| Upside Intraday Target | 32.26 |
| Upside Intraday Target | 32.7 |
| Downside Intraday Target | 31.77 |
Weekly technical analysis of Supernus Pharmaceuticals (SUPN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 06 Thu Mar 2025 | 31.82 | 32.01 | 32.21 | 31.28 | 0.653 times |
| 28 Fri Feb 2025 | 32.06 | 33.36 | 34.10 | 30.37 | 1.076 times |
| 21 Fri Feb 2025 | 33.05 | 39.09 | 39.99 | 32.53 | 2.826 times |
| 14 Fri Feb 2025 | 39.11 | 38.32 | 39.59 | 37.43 | 0.584 times |
| 07 Fri Feb 2025 | 38.40 | 37.86 | 40.28 | 36.12 | 1.897 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Supernus Pharmaceuticals (SUPN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 06 Thu Mar 2025 | 31.82 | 32.01 | 32.21 | 31.28 | 0.232 times |
| 28 Fri Feb 2025 | 32.06 | 37.86 | 40.28 | 30.37 | 1.857 times |
| 31 Fri Jan 2025 | 38.37 | 36.27 | 39.88 | 36.10 | 1.24 times |
| 31 Tue Dec 2024 | 36.16 | 37.19 | 37.62 | 34.38 | 0.701 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Supernus Pharmaceuticals (SUPN)
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Supernus Pharmaceuticals in short term and the sell signal is strong.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Supernus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Supernus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 32.15 and Supernus Pharmaceuticals (SUPN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Supernus Pharmaceuticals (SUPN) stock. Volume based technical analysis of Supernus Pharmaceuticals (SUPN) stock is negative.
Supernus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Supernus Pharmaceuticals in short term and the sell signal is strong.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Supernus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Supernus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 32.15 and Supernus Pharmaceuticals (SUPN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Supernus Pharmaceuticals (SUPN) stock. Volume based technical analysis of Supernus Pharmaceuticals (SUPN) stock is negative.
Supernus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.